Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-11.56	25.66	29.01
Graham Fair Price	6.79	1.25	1.17
PEG	100.00	0.31	0.00
Price/Book	-1.70	-14.73	-14.48
Price/Cash Flow	2182.53	-501.22	21.96
Prices/Earnings	-41.71	12.53	21.50
Price/Sales	-18.86	4.08	5.03
Price/FCF	2182.53	-501.22	21.96
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.58	0.73	0.72
Operating Margin	0.16	0.19	0.19
ROA	43.46	0.02	0.01
ROE	-0.17	-0.29	-74.46
ROIC	0.02	0.04	66.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-190.99
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.33	0.02	-93.25
EPS QOQ	0.00	0.40	100.00
FCF QOQ	0.68	-1.04	53.10
Revenue QOQ	0.01	0.02	68.43
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-12.61	-14.14	-12.12
Days Sales Outstanding (DSO)	24.20	23.77	-1.76
Inventory Turnover	-7.14	-6.37	10.81
Debt/Capitalization	1.10	1.08	-1.83
Quick Ratio	2.28	2.47	8.65
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-0.60	-0.49	19.15
Cash	2.87	2.82	-1.83
Capex	-0.07	-0.09	-41.35
Free Cash Flow	0.40	-0.01	-96.40
Revenue	1.73	1.76	1.34
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.48	2.73	9.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.21	9.25	0.39
Naive Interpretation	Member

06 - Financial Health · Bad

Rating